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Background
Recent landmark studies like the MR-IMPACT and CE-
MARC have demonstrated the advantage of stress CMR
over other imaging modalities in ischaemia detection of
coronary artery disease. However to date there are no
studies demonstrating how stress CMR influences
patient management in clinical practice.
Methods
A retrospective cohort of 2139 patients who had undergone
both adenosine stress CMR (2008-2011) and a coronary
angiographic procedure (2006 to 2011) was identified. 142
patients with a diagnosis of cardiomyopathy and 98 patients
with previous CABG were excluded. 1899 patients com-
prised the study group with the latest date of followup
being 31.8.2012. Data was extracted from each patient’s
hospital health record and analysed using STATA version
8.0. This study was undertaken as part of clinical service
evaluation.
Results
Indications for stress CMR were: symptomatic chest pain
(74%), assessment of functional significance of residual
coronary disease (12%), assessment of LV function (12%)
and nonspecified reasons (2%). Inducible perfusion defects
were identified in 1546 (81%) patients among whom 534
(35%) had had prior angiographic assessment. 224 patients
underwent percutaneous intervention (PCI) post CMR
with the majority performed in those with perfusion
defects (92%, n=206). In these 206 patients, the perfusion
defect matched the territory of the stented coronary vessel
in 89% (187) patients. The median time to PCI was 77
days (IQR 37-134) in the matched defect group and 157
days (IQR 79-488) in the unmatched defect group,
p<0.003. On follow up (1.6±0.85years), 72% (n=149)
denied any symptoms, 18% (n=38) had ongoing symptoms
and 9% (n=19) had had a repeat revascularisation proce-
dure. 2% (n=5) patients died during follow up.
Conclusions
We have demonstrated that stress CMR can both guide
percutaneous intervention and influence patient manage-
ment. To our knowledge, this is the first study demon-
strating not only the diagnostic utility of stress CMR but
also its integration into contemporary clinical practice.
Further research is needed to determine how it can
further improve patient outcomes.
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